Frank Lutterodt

SM16, an Orally Active TGF-β Type I Receptor Inhibitor Prevents Myofibroblast Induction and Vascular Fibrosis in the Rat Carotid Injury Model

Kai Fu, Michael J. Corbley, Lihong Sun et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2008 · 84 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Potent and Orally Bioavailable 8-Bicyclo[2.2.2]octylxanthines as Adenosine A₁ Receptor Antagonists

William F. Kiesman, Jin Zhao, Patrick R. Conlon et al. · Journal of Medicinal Chemistry · 2006 · 42 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Norbornyllactone-substituted xanthines as adenosine A1 receptor antagonists

William F. Kiesman, Jin Zhao, Patrick R. Conlon et al. · Bioorganic & Medicinal Chemistry · 2006 · 20 citations

Medicine, Medicinal Chemistry, Pharmacology +7

Tricyclic Imidazoline Derivatives as Potent and Selective Adenosine A₁Receptor Antagonists

Chi B. Vu, William F. Kiesman, Patrick R. Conlon et al. · Journal of Medicinal Chemistry · 2006 · 14 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Renal effects of BG9928, an A₁ adenosine receptor antagonist, in rats and nonhuman primates

Barry Ticho, E. Whalley, Alan Gill et al. · Drug Development Research · 2003 · 13 citations

Medicine, Pharmacology, Pharmacotherapy +10